Ectopic expression of Bcl-XL or Ku70 protects human colon cancer cells (SW480) against curcumin-induced apoptosis while their down-regulation potentiates it

Carcinogenesis

Volumn 25, Issue 10, 2004, Pages 1867-1877

  Rashmi, Ramachandran ^a   Kumar, Santhosh ^a   Karunagaran, Devarajan ^a  

^a RAJIV GANDHI CENTRE FOR BIOTECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; APOPTOSIS INDUCING FACTOR; CASPASE 3; CASPASE 8; CASPASE 9; CURCUMIN; CYTOCHROME C; GREEN FLUORESCENT PROTEIN; KU ANTIGEN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CELL DEATH; CELL NUCLEUS; CELL PROTECTION; COLON CANCER; CONTROLLED STUDY; CYTOSOL; DOWN REGULATION; DRUG SENSITIVITY; DRUG SENSITIZATION; ENZYME ACTIVATION; ENZYME INHIBITION; FEEDBACK SYSTEM; GENE CONSTRUCT; GENE OVEREXPRESSION; GENE VECTOR; GENETIC STABILITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN SECRETION; PROTEIN TRANSPORT;

ANTIGENS, NUCLEAR; ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS INDUCING FACTOR; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CASPASES; COLONIC NEOPLASMS; COMPLEMENT SYSTEM PROTEINS; CURCUMIN; CYTOCHROMES C; DNA REPAIR; DNA-BINDING PROTEINS; DOWN-REGULATION; ENZYME ACTIVATION; FLAVOPROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; GREEN FLUORESCENT PROTEINS; HUMANS; LUMINESCENT PROTEINS; MEMBRANE PROTEINS; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED;

EID: 6444242124     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh213     Document Type: Article

References (50)

1. Ruby,A.J., Kuttan,G., Babu,K.D., Rajasekharan,K.N. and Kuttan,R. (1995) Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett., 94, 79-83.
2. Anto,R.J., George,J., Babu,K.V., Rajasekharan,K.N. and Kuttan,R. (1996) Antimutagenic and anticarcinogenic activity of natural and synthetic curcuminoids. Mutat. Res., 370, 127-131.
3. Kuo,M.L., Huang,T.S. and Lin,J.K. (1996) Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells. Biochim. Biophys. Acta, 1317, 95-100.
4. Piwocka,K., Zablocki,K., Wieckowski,M.R., Skierski,J., Feiga,I., Szopa,J., Drela,N., Wojtczak,L. and Sikora,E. (1999) A novel apoptosis-like pathway, independent of mitochondria and caspases, induced by curcumin in human lymphoblastoid T (Jurkat) cells. Exp. Cell Res. 249, 299-307.
5. Chen,H., Zhang,Z.S., Zhang,Y.L. and Zhou,D.Y. (1999) Curcumin inhibits cell proliferation by interfering with the cell cycle and inducing apoptosis in colon carcinoma cells. Anticancer Res., 19 3675-3680.
6. Gautam,S.C., Xu,Y.X., Pindolia,K.R., Janakiraman,N. and Chapman,R.A. (1998) Nonselective inhibition of proliferation of transformed and nontransformed cells by the anticancer agent curcumin (diferuloylmethane). Biochem. Pharmacol., 55, 1333-1337.
7. Hong,R.L., Spohn,W.H. and Hung,M.C. (1999) Curcumin inhibits tyrosine kinase activity of p185neu and also depletes p185neu. Clin. Cancer Res., 5, 1884-1991.
8. Vaux,D.L., Cory,S. and Adams,J.M. (1988) Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature, 335, 440-442.
9. Boise,L.H., Gonzalez-Garcia,M., Postema,C.E., Ding,L., Lindsten,T., Turka,L.A., Mao,X., Nunez,G. and Thompson,C.B. (1993) bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell, 74, 597-608.
10. Deveraux,Q.L., Takahashi,R., Salvesen,G.S. and Reed,J.C. (1997) X-linked IAP is a direct inhibitor of cell-death proteases. Nature, 388, 300-304.
11. Jaattela,M., Wissing,D., Bauer,P.A. and Li,G.C. (1992) Major heat shock protein hsp70 protects tumor cells from tumor necrosis factor cytotoxicity. EMBO J., 11, 3507-3512.
12. Mosser,D.D., Caron,A.W., Bourget,L., Denis-Larose,C. and Massie,B. (1997) Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis. Mol. Cell Biol., 17, 5317-5327.
13. Gautschi,O., Tschopp,S., Olie,R.A. et al. (2001) Activity of a novel bcl-2/ bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins. J. Natl Cancer Inst., 93, 463-4671.
14. Olopade,O.I., Adeyanju,M.O., Safa,A.R., Hagos,F., Mick,R., Thompson,C.B. and Recant,W.M. (1997) Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases. Cancer J. Sci. Am., 3, 230-237.
15. Krajewska,M., Moss,S.F., Krajewski,S., Song,K., Holt,P.R. and Reed,J.C. (1996) Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas. Cancer Res., 56, 2422-2427.
16. Rosen,K., Rak,J., Jin,J., Kerbel,R.S., Newman,M.J. and Filmus,J. (1998) Downregulation of the pro-apoptotic protein Bak is required for the ras-induced transformation of intestinal epithelial cells. Curr. Biol., 8, 1331-1334.
17. Rosen,K., Rak,J., Leung,T., Dean,N.M., Kerbel,R.S. and Filmus,J. (2000) Activated Ras prevents downregulation of Bcl-X (L) triggered by detachment from the extracellular matrix. A mechanism of Ras-induced resistance to anoikis in intestinal epithelial cells. J. Cell Biol., 149, 447-456.
18. Leech,S.H., Olie,R.A., Gautschi,O., Simoes-Wust,A.P., Tschopp,S., Haner,R., Hall,J., Stahel,R.A. and Zangemeister-Wittke,U. (2000) Induction of apoptosis in lung-cancer cells following bcl-xL anti-sense treatment. Int. J. Cancer, 86, 570-576.
19. Zangemeister-Wittke,U., Schenker,T., Luedke,G.H. and Stahel,R.A. (1998) Synergistic cytotoxicity of bcl-2 antisense oligodeoxynucleotides and etoposide, doxorubicin and cisplatin on small-cell lung cancer cell lines. Br. J. Cancer, 78, 1035-1042.
20. Sawada,M., Sun,W., Hayes,P., Leskov,K., Boothman,D.A. and Matsuyama,S. (2003) Ku70 suppresses the apoptotic translocation of Bax to mitochondria. Nature Cell Biol., 5, 320-329.
21. Wilson,C.R., Davidson,S.E., Margison,G.P., Jackson,S.P., Hendry,J.H. and West,C.M. (2000) Expression of Ku70 correlates with survival in carcinoma of the cervix. Br. J. Cancer, 83, 1702-1706.
22. Zhao,H.J., Hosoi,Y., Miyachi,H., Ishii,K., Yoshida,M., Nemoto,K., Takai,Y., Yamada,S., Suzuki,N. and Ono,T. (2000) DNA-dependent protein kinase activity correlates with Ku70 expression and radiation sensitivity in esophageal cancer cell lines. Clin. Cancer Res., 6, 1073-1078.
23. Anto,R.J., Maliekal,T.T. and Karunagaran,D. (2000) L-929 cells harboring ectopically expressed RelA resist curcumin-induced apoptosis. J. Biol. Chem., 275, 15601-15604.
24. Rashmi,R., Santhosh Kumar,T.R. and Karunagaran,D. (2003) Human colon cancer cells differ in their sensitivity to curcumin-induced apoptosis and heat shock protects them by inhibiting the release of apoptosis-inducing factor and caspases. FEBS Lett., 538, 19-24.
25. Rashmi,R., Kumar,S. and Karunagaran,D. (2004) Ectopic expression of Hsp70 confers resistance and silencing its expression sensitizes human colon cancer cells to curcumin-induced apoptosis. Carcinogenesis, 25, 179-187.
26. Alley,M.C., Scudiero,D.A., Monks,A., Hursey,M.L., Czerwinski,M.J., Fine,D.L., Abbott,B.J., Mayo,J.G., Shoemaker,R.H. and Boyd,M.R. (1988) Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res., 48, 599-601.
27. Ito,A., Uehara,T., Tokumitsu,A., Okuma,Y. and Nomura,Y. (1999) Possible involvement of cytochrome c release and sequential activation of caspases in ceramide-induced apoptosis in SK-N-MC cells. Biochim. Biophys. Acta, 1452, 263-274.
28. Zhang,L., Yu,J., Park,B.H., Kinzler,K.W. and Vogelstein,B. (2000) Role of BAX in the apoptotic response to anticancer agents. Science, 290, 989-92.
29. Tsujimoto,Y. (1998) Role of Bcl-2 family proteins in apoptosis: apoptosomes or mitochondria? Genes Cells, 3, 697-707.
30. Tewari,M., Quan,L.T., O'Rourke,K., Desnoyers,S., Zeng,Z., Beidler,D.R., Poirier,G.G., Salvesen,G.S. and Dixit,V.M. (1995) Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly (ADP-ribose) polymerase. Cell, 81, 801-909.
31. Cory,S. and Adams,J.M. (2002) The Bcl2 family: regulators of the cellular life-or-death switch. Nature Rev. Cancer, 2, 647-656.
32. Zou,H., Li,Y., Liu,X. and Wang,X. (1999) An APAF-1. cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem., 274, 11549-11556.
33. Kluck,R.M., Bossy-Wetzel,E., Green,D.R. and Newmeyer,D.D. (1997) The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science, 275, 1132-1136.
34. Vander Heiden,M.G., Chandel,N.S., Williamson,E.K., Schumacker,P.T. and Thompson,C.B. (1997) Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell, 91, 627-637.
35. Coll,M.L., Rosen,K., Ladeda,V. and Filmus,J. (2002) Increased Bcl-xL expression mediates v-Src-induced resistance to anoikis in intestinal epithelial cells. Oncogene, 21, 2908-2913.
36. Anto,R.J., Mukhopadhyay,A., Denning,K. and Aggarwal,B.B. (2002) Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis, 23, 143-150.
37. Kim,S.H., Kim,D., Han,J.S., Jeong,C.S., Chung,B.S., Kang,C.D. and Li,G.C. (1999) Ku autoantigen affects the susceptibility to anticancer drugs. Cancer Res., 59, 4012-4017.
38. Jiang,M.C., Yang-Yen,H.F., Lin,J.K. and Yen,J.J. (1996) Differential regulation of p53, c-Myc, Bcl-2 and Bax protein expression during apoptosis induced by widely divergent stimuli in human hepatoblastoma cells. Oncogene, 13, 609-616.
39. Woo,J.H., Kim,Y.H., Choi,Y.J. et al. (2003) Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt. Carcinogenesis, 24, 1199-1208.
40. Choudhuri,T., Pal,S., Agwarwal,M.L., Das,T. and Sa,G. (2002) Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction. FEBS Lett., 512, 334-340.
41. Stegh,A.H., Barnhart,B.C., Volkland,J., Algeciras-Schimnich,A., Ke,N., Reed,J.C. and Peter,M.E. (2002) Inactivation of caspase-8 on mitochondria of Bcl-xL-expressing MCF7-Fas cells: role for the bifunctional apoptosis regulator protein. J. Biol. Chem., 277, 4351-4360.
42. Yin,X.M., Wang,K., Gross,A., Zhao,Y., Zinkel,S., Klocke,B., Roth,K.A. and Korsmeyer,S.J. (1999) Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature, 400, 886-891.
43. Slee,E.A., Adrain,C. and Martin,S.J. (1999) Serial killers: ordering caspase activation events in apoptosis. Cell Death Differ. 6, 1067-1074.
44. Slee,E.A., Harte,M.T., Kluck,R.M. et al. (1999) Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8 and -10 in a caspase-9-dependent manner. J. Cell Biol., 144, 281-292.
45. Slee,E.A., Adrain,C. and Martin,S.J. (2001) Executioner caspase-3, -6 and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J. Biol. Chem., 276, 7320-7326.
46. Arnoult,D., Parone,P., Martinou,J.C., Antonsson,B., Estaquier,J. and Ameisen,J.C. (2002) Mitochondrial release of apoptosis-inducing factor occurs downstream of cytochrome c release in response to several proapoptotic stimuli. J. Cell Biol., 150, 923-929.
47. Arnoult,D., Gaume,B., Karbowski,M., Sharpe,J.C., Cecconi,F. and Youle,R.J. (2003) Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax/Bak-mediated permeabilization. EMBO J., 22, 4385-4399.
48. Du,C., Fang,M., Li,Y., Li,L. and Wang,X. (2000) Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell, 102, 33-42.
49. Vucic,D., Deshayes,K., Ackerly,H., Pisabarro,M.T., Kadkhodayan,S., Fairbrother,W.J. and Dixit,V.M. (2002) SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-IAP). J. Biol. Chem., 277, 12275-12279.
50. Tsujimoto,Y. (2003) Cell death regulation by the Bcl-2 protein family in the mitochondria. J. Cell. Physiol., 195, 158-167.